Huawei unveils its first continuous glucose monitor in China

Huawei has revealed its first-ever continuous glucose monitor, known as the HUAWEI Sence G1, in China. The device is designed to work alongside other Huawei products, enabling users to track their glucose levels on a smartphone, smartwatch, or fitness band while receiving alerts for unusual spikes or dips. VP Bruce Lee noted that the product has been in development for over three years, making it one of the company's longest-mastered products. The device was approved by China’s National Medical Products Administration as Huawei’s first Class III medical device, though pricing and global availability details have not yet been shared.